Comparison of human and rat uterine leiomyomata: Identification of a dysregulated mammalian target of rapamycin pathway

Cancer Research

Volumn 69, Issue 15, 2009, Pages 6171-6178

  Crabtree, Judy S ^a   Jelinsky, Scott A ^a   Harris, Heather A ^a   Choe, Sung E ^a   Cotreau, Monette M ^a   Kimberland, Michelle L ^a   Wilson, Ewa ^a   Saraf, Kathryn A ^a   Liu, Wei ^a   McCampbell, Adrienne S ^b   Dave, Bhuvanesh ^c   Broaddus, Russell R ^b   Brown, Eugene L ^a   Kao, Wenling ^d   Skotnicki, Jerauld S ^d   Abou Gharbia, Magid ^d   Winneker, Richard C ^a   Walker, Cheryl L ^c  

^a PFIZER INC   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF TEXAS   (United States)

^d WYETH RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MESSENGER RNA; RAPAMYCIN DERIVATIVE; UNCLASSIFIED DRUG; WAY 129327;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER INCIDENCE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; HUMAN VERSUS ANIMAL COMPARISON; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION; UTERUS MYOMA;

ANIMALS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LEIOMYOMA; MYOMETRIUM; PROTEIN ARRAY ANALYSIS; PROTEIN KINASES; RATS; SIGNAL TRANSDUCTION; UTERINE NEOPLASMS;

EID: 68049140801     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-08-4471     Document Type: Article

References (39)

1. Cramer S, Patel A. The frequency of uterine leiomyomas. Am J Clin Pathol 1990;94:435-438
2. Walker CL, Stewart EA. Uterine fibroids: the elephant in the room. Science 2005;308:1589-1592
3. Arslan AA, Gold LI, Mittal K, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod 2005;20:852-863 (Pubitemid 40667828)
4. Newbold RR, Moore AB, Dixon D. Characterization of uterine leiomyomas in CD-1 mice following developmental exposure to diethylstilbestrol (DES). Toxicol Pathol 2002;30:611-616
5. Politi K, Szabolcs M, Fisher P, Kljuic A, Ludwig T, Efstratiadis A. A mouse model of uterine leiomyosarcoma. Am J Pathol 2004;164:325-336
6. Romagnolo B, Molina T, Leroy G, et al. Estradiol-dependent uterine leiomyomas in transgenic mice. J Clin Invest 1996;98:777-784 (Pubitemid 26349183)
7. Walker CL, Hunter D, Everitt JI. Uterine leiomyoma in the Eker rat: a unique model for important diseases of women. Genes Chromosomes Cancer 2003;38:349-356 (Pubitemid 37466936)
8. Porter KB, Tsibris JC, Porter GW, et al. Effects of raloxifene in a guinea pig model for leiomyomas. Am J Obstet Gynecol 1998;179:1283-1287 (Pubitemid 28533788)
9. Porter KB, Tsibris JC, Porter GW, O'Brien WF, Spellacy WN. Use of endoscopic and ultrasound techniques in the guinea pig leiomyoma model. Lab Anim Sci 1997;47: 537-539 (Pubitemid 127515130)
10. Tsibris JC, Porter KB, Jazayeri A, et al. Human uterine leiomyomata express higher levels of peroxisome proliferator-activated receptor γ, retinoid X receptor α, and all-trans retinoic acid than myometrium. Cancer Res 1999;59:5737-5744
11. Mozzachio K, Linder K, Dixon D. Uterine smooth muscle tumors in potbellied pigs (Sus scrofa) resemble human fibroids: a potential animal model. Toxicol Pathol 2004;32:402-407 (Pubitemid 38998932)
12. Cook JD, Walker CL. The Eker rat: establishing a genetic paradigm linking renal cell carcinoma and uterine leiomyoma. Curr Mol Med 2004;4:813-824
13. Eker R, Mossige J. A dominant gene for renal adenomas in the rat. Nature 1961;189:856-859
14. Kobayashi T, Hirayama Y, Kobayashi E, Kubo Y, Hino O. A germline insertion in the tuberous sclerosis (Tsc2) gene gives rise to the Eker rat model of dominantly inherited cancer. Nat Genet 1995;9:70-74
15. Yeung RS, Buetow KH, Testa JR, Knudson AG, Jr. Susceptibility to renal carcinoma in the Eker rat involves a tumor suppressor gene on chromosome 10. Proc Natl Acad Sci U S A 1993;90:8038-8042
16. Chiang GG, Abraham RT. Targeting the mTOR signaling network in cancer. Trends Mol Med 2007;13: 433-442 (Pubitemid 47570021)
17. Tsang CK, Qi H, Liu LF, Zheng XS. Targeting mammalian target of rapamycin (mTOR) for health and diseases. Drug Discov Today 2006;12:112-124
18. Cotreau MM, Chennathukuzhi VM, Harris HA, et al. A study of 17h-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy. Maturitas 2007;58:366-376
19. Baldi P, Long AD. A Bayesian framework for the analysis of microarray expression data: regularized t -test and statistical inferences of gene changes. Bioinformatics 2001;17:509-519 (Pubitemid 32600497)
20. Smyth GK. Limma: linear models for microarray data. In: Gentleman R, Carey V, Dudoit S, Irizarry R, Huber W, editors. Bioinformatics and Computational Biology Solutions using R and Bioconductor R. New York: Springer; 2005. p. 397-420.
21. Sayers EW, Barrett T, Benson DA, et al. Database resources of the National Center for Biotechnology Information. Nucleic Acids Res 2009;37:D5-15. (Pubitemid 40207828)
22. Tian L, Greenberg SA, Kong SW, Altschuler J, Kohane IS, Park PJ. Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A 2005;102:13544-13549 (Pubitemid 41420885)
23. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-15550 (Pubitemid 41528093)
24. Howe SR, Gottardis MM, Everitt JI, Goldsworthy TL, Wolf DC, Walker CL. Rodent model of reproductive tract leiomyomata. Establishment and characterization of tumor-derived cell lines. Am J Pathol 1995;146:1568-1579
25. Peng T, Golub TR, Sabatini DM. The immunosuppressant rapamycin mimics a starvation-like signal distinct from amino acid and glucose deprivation. Mol Cell Biol 2002;22:5575-5584 (Pubitemid 34755766)
26. Cunningham JT, Rodgers JT, Arlow DH, Vazquez F, Mootha VK, Puigserver P. mTOR controls mitochondrial oxidative function through a YY1-PGC-1a transcriptional complex. Nature 2007;450:736-740 (Pubitemid 350207689)
27. McMahon LP, Choi KM, Lin T-A, Abraham RT, Lawrence JC, Jr. The rapamycin-binding domain governs substrate selectivity by the mammalian target of rapamycin. Mol Cell Biol 2002;22:7428-7438
28. Wang X, Beugnet A, Murakami M, Yamanaka S, Proud CG. Distinct signaling events downstream of mTOR cooperate to mediate the effects of amino acids and insulin on initiation factor 4E-binding proteins. Mol Cell Biol 2005;25:2558-2572 (Pubitemid 40381622)
29. Schwartz SM, Marshall LM, Baird DD. Epidemiological contributions to understanding the etiology of uterine leiomyomata. Environ Health Perspect 2000;108: 821-827
30. Lobel MK, Somasundaram P, Morton CC. The genetic heterogeneity of uterine leiomyomata. Obstet Gynecol Clin North Am 2006;33:13-39.
31. Chwalisz K, Larsen L, Mattia-Goldberg C, Edmonds A, Elger W, Winkel C. A randomized, controlled trial of asoprisnil, a novel selective progesterone receptor modulator, in women with uterine leiomyomata. Fertil Steril 2007;87:1399-1412 (Pubitemid 46829155)
32. Geiser A, Hummel CW, Draper MW, et al. A new selective estrogen receptor modulator with potent uterine antagonist activity in bone, and minimal ovarian stimulation. Endocrinology 2005;146:4524-4535 (Pubitemid 41324051)
33. Skubitz KM, Skubitz AP. Differential gene expression in uterine leiomyoma. J Lab Clin Med 2003;141: 297-308. (Pubitemid 36581910)
34. Jelinsky SA, Choe SE, Crabtree JS, et al. Molecular analysis of the vaginal response to estrogens in the ovariectomized rat and postmenopausal women. BMC Med Genomics 2008;1:27-38.
35. McCarroll SA, Murphy CT, Zou S, et al. Comparing genomic expression patterns across species identifies shared transcriptional profile in aging. Nat Genet 2004; 36:197-204. (Pubitemid 38174381)
36. Kenerson H,Dundon TA, Yeung RS. Effects of rapamycin in the Eker rat model of tuberous sclerosis complex. Pediatr Res 2005;57:67-75. (Pubitemid 40039895)
37. Suzuki T, Kopia G, Hayashi S-I, et al. Stent-based delivery of sirolimus reduces neointimal formation in a porcine coronary model. Circulation 2001;104:1188-1193 (Pubitemid 32830406)
38. Chang SB, Miron P,Miron A, Iglehart JD. Rapamycin inhibits proliferation of estrogen-receptor positive breast cancer cells. J Surg Res 2007;138:37-44. (Pubitemid 46227456)
39. Yin XJ, Wang G, Khan-Dawood FS. Requirements of phosphatidylinositol-3 kinase and mammalian target of rapamycin for estrogen-induced proliferation in uterine leiomyoma- and myometrium-derived cell lines. Am J Obstet Gynecol 2007;196:176e1-5 (Pubitemid 46251376)